BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 34829513)

  • 21. Application of Magnetic Resonance Imaging in Neoadjuvant Treatment of Pancreatic Ductal Adenocarcinoma.
    Qu C; Zeng PE; Wang HY; Yuan CH; Yuan HS; Xiu DR
    J Magn Reson Imaging; 2022 Jun; 55(6):1625-1632. PubMed ID: 35132729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging preoperatively for pancreatic adenocarcinoma.
    Pietryga JA; Morgan DE
    J Gastrointest Oncol; 2015 Aug; 6(4):343-57. PubMed ID: 26261722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification.
    Gilbert JW; Wolpin B; Clancy T; Wang J; Mamon H; Shinagare AB; Jagannathan J; Rosenthal M
    Ann Oncol; 2017 Sep; 28(9):2067-2076. PubMed ID: 28407088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incremental Role of Pancreatic Magnetic Resonance Imaging after Staging Computed Tomography to Evaluate Patients with Pancreatic Ductal Adenocarcinoma.
    Kim HJ; Park MS; Lee JY; Han K; Chung YE; Choi JY; Kim MJ; Kang CM
    Cancer Res Treat; 2019 Jan; 51(1):24-33. PubMed ID: 29397657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Medical oncology and pancreatic cancer: what the radiologist needs to know.
    Fogelman DR; Varadhachary G
    Abdom Radiol (NY); 2018 Feb; 43(2):383-392. PubMed ID: 29285600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multimodality management of borderline resectable pancreatic adenocarcinoma.
    Prakash LR; Katz MHG
    Chin Clin Oncol; 2017 Jun; 6(3):27. PubMed ID: 28705004
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New challenges in perioperative management of pancreatic cancer.
    Puleo F; Maréchal R; Demetter P; Bali MA; Calomme A; Closset J; Bachet JB; Deviere J; Van Laethem JL
    World J Gastroenterol; 2015 Feb; 21(8):2281-93. PubMed ID: 25741134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial.
    Murphy JE; Wo JY; Ryan DP; Jiang W; Yeap BY; Drapek LC; Blaszkowsky LS; Kwak EL; Allen JN; Clark JW; Faris JE; Zhu AX; Goyal L; Lillemoe KD; DeLaney TF; Fernández-Del Castillo C; Ferrone CR; Hong TS
    JAMA Oncol; 2018 Jul; 4(7):963-969. PubMed ID: 29800971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline Resectable and Locally Advanced Pancreatic Cancer: FDG PET/MRI and CT Tumor Metrics for Assessment of Pathologic Response to Neoadjuvant Therapy and Prediction of Survival.
    Panda A; Garg I; Truty MJ; Kline TL; Johnson MP; Ehman EC; Suman G; Anaam DA; Kemp BJ; Johnson GB; Halfdanarson TR; Venkatesh SK; Fidler JL; Goenka AH
    AJR Am J Roentgenol; 2021 Sep; 217(3):730-740. PubMed ID: 33084382
    [No Abstract]   [Full Text] [Related]  

  • 30. A preoperative risk model for early recurrence after radical resection may facilitate initial treatment decisions concerning the use of neoadjuvant therapy for patients with pancreatic ductal adenocarcinoma.
    Guo SW; Shen J; Gao JH; Shi XH; Gao SZ; Wang H; Li B; Yuan WL; Lin L; Jin G
    Surgery; 2020 Dec; 168(6):1003-1014. PubMed ID: 32321665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical resection rates after neoadjuvant therapy for localized pancreatic ductal adenocarcinoma: meta-analysis.
    Brown ZJ; Heh V; Labiner HE; Brock GN; Ejaz A; Dillhoff M; Tsung A; Pawlik TM; Cloyd JM
    Br J Surg; 2022 Dec; 110(1):34-42. PubMed ID: 36346716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The past, present, and future status of multimodality treatment for resectable/borderline resectable pancreatic ductal adenocarcinoma.
    Sakaguchi T; Satoi S; Yamamoto T; Yamaki S; Sekimoto M
    Surg Today; 2020 Apr; 50(4):335-343. PubMed ID: 31993761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of pancreatic cancer-neoadjuvant treatment in borderline resectable/locally advanced pancreatic cancer.
    Scheufele F; Hartmann D; Friess H
    Transl Gastroenterol Hepatol; 2019; 4():32. PubMed ID: 31231699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CT Texture Analysis of Ductal Adenocarcinoma Downstaged After Chemotherapy.
    Ciaravino V; Cardobi N; DE Robertis R; Capelli P; Melisi D; Simionato F; Marchegiani G; Salvia R; D'Onofrio M
    Anticancer Res; 2018 Aug; 38(8):4889-4895. PubMed ID: 30061265
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial.
    van Dongen JC; Versteijne E; Bonsing BA; Mieog JSD; de Hingh IHJT; Festen S; Patijn GA; van Dam R; van der Harst E; Wijsman JH; Bosscha K; van der Kolk M; de Meijer VE; Liem MSL; Busch OR; Besselink MGH; van Tienhoven G; Groot Koerkamp B; van Eijck CHJ; Suker M;
    Eur J Surg Oncol; 2023 Apr; 49(4):811-817. PubMed ID: 36585300
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neoadjuvant Treatments for Pancreatic Ductal Adenocarcinoma: Where We Are and Where We Are Going.
    Coppola A; Farolfi T; La Vaccara V; Iannone I; Giovinazzo F; Panettieri E; Tarallo M; Cammarata R; Coppola R; Caputo D
    J Clin Med; 2023 May; 12(11):. PubMed ID: 37297872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreas-protocol imaging at a high-volume center leads to improved preoperative staging of pancreatic ductal adenocarcinoma.
    Walters DM; Lapar DJ; de Lange EE; Sarti M; Stokes JB; Adams RB; Bauer TW
    Ann Surg Oncol; 2011 Oct; 18(10):2764-71. PubMed ID: 21484522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma.
    Álvarez R; Alés I; Díaz R; de Paredes BG; Hidalgo M
    Clin Transl Oncol; 2017 Oct; 19(10):1193-1198. PubMed ID: 28612203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades.
    Taboada AGM; Lominchar PL; Roman LM; García-Alfonso P; Martin AJM; Rodriguez JAB; Pascual JMA
    Ann Hepatobiliary Pancreat Surg; 2021 May; 25(2):179-191. PubMed ID: 34053920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contemporary management of borderline resectable pancreatic ductal adenocarcinoma.
    Lekka K; Tzitzi E; Giakoustidis A; Papadopoulos V; Giakoustidis D
    Ann Hepatobiliary Pancreat Surg; 2019 May; 23(2):97-108. PubMed ID: 31225409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.